Hoag Health System

Hoag is redefining women’s health by providing expert, evidence-based menopause care for every stage of life. 💜 Our Menopause Program, led by specialists like Dr. Lisa Karamardian, combines the latest research with a multidisciplinary approach to help women manage symptoms, protect long-term health, and maintain quality of life. Our team includes OB/GYNs, menopause certified providers, wellness experts, and mental health professionals, ensuring a comprehensive, whole-person approach that addresses physical, emotional, and lifestyle needs. Trusted by thousands of women across Orange County, Hoag is proud to set the standard in menopause care. Learn more: https://bit.ly/46H5pUd. #WorldMenopauseDay

We're #hiring a new Clinical Nurse I : Heart Catherization Lab - Per Diem - 08HR - Hoag Newport Beach in Newport Beach, California. Apply today or share this post with your network.

Hoag’s Oncoplastic Breast Surgery Program gives women the opportunity to treat breast cancer without compromising the look of their breast. By combining cancer removal with advanced plastic surgery techniques in a single procedure, surgeons can remove the tumor and often restore or even improve the breast’s appearance. How this program benefits patients ➡ Conserves the breast while eliminating defects left by standard lumpectomy
 ➡ Most procedures are outpatient with recovery in just a couple of weeks
 ➡ Combines with radiation to provide survival rates equal to mastectomy
 ➡ Aims to remove cancer completely in a single surgery with excellent cosmetic results
 ➡ Improves quality of life and satisfaction for breast cancer patients Hoag’s program is nationally recognized for its expertise and low re-excision rates. Every procedure is more than a surgery, it’s a step toward healing, confidence, and reclaiming life. We are committed to delivering care that not only treats the cancer but also supports patients’ physical and emotional well-being. #BreastCancerAwarenessMonth

We're #hiring a new CLINICAL NURSE I MCH FLOAT II - NURSING STAFFING OFFICE in Newport Beach, California. Apply today or share this post with your network.

When Kayvon Goodarzy was diagnosed with glioblastoma in 2024, he and his care team faced a critical challenge. Standard therapies for this aggressive brain tumor, including radiation and chemotherapy, have historically shown limited effectiveness, and few treatment advancements have emerged in recent decades. Kayvon is now the first patient worldwide to receive a combination of a Natural Killer (NK) cell immunotherapy clinical trial along with a specialized electric field device designed to disrupt tumor growth. Early results have been highly encouraging. “This therapeutic approach has the potential to be groundbreaking if validated in larger trials,” says Dr. Simon Khagi, Medical Director of Neuro-Oncology at Hoag. “Its potential cannot be overstated. It is historic.” By combining the Optune electric field device with NK cell therapy and N803 protein injections, the treatment aims to enhance the immune system’s ability to target cancer cells while minimizing damage to healthy tissue. Kayvon’s experience is helping clinicians understand the potential synergy between these modalities and may inform future trial designs and standard of care strategies. Kayvon’s journey exemplifies the importance of patient-centered innovation and rigorous clinical investigation. His participation is providing valuable insights that could expand treatment possibilities for glioblastoma patients globally.

We're #hiring a new Multiskilled Facilities Eng I : Engineering - Full Time - 08HR - Hoag Newport Beach in Newport Beach, California. Apply today or share this post with your network.

Invasive lobular carcinoma (ILC) is a distinct type of breast cancer that can be harder to detect than other forms, making awareness, early detection, and advanced imaging critical for patients. Here are the facts: → 10–15% of all breast cancers are invasive lobular carcinoma, the second most common type of breast cancer. → 43,000 new cases of ILC are diagnosed each year, affecting more women than cancers of the kidney, brain, pancreas, liver, or ovaries. → ILC tumors often grow in threadlike patterns rather than forming a lump, making them harder to detect with self-exams or standard mammograms. → Symptoms can include firmness, dimpling, swelling, or changes in the nipple or breast, but sometimes there are no symptoms at all. → ILC can spread to less common sites, including the gastrointestinal tract, ovaries, abdominal lining, and in rare cases tissues around the eyes or the brain and spinal cord. → ILC can recur many years after initial diagnosis, sometimes more than 10 years later. At Hoag, Dr. Gary Ulaner, Medical Director of Molecular Imaging & Therapy, is leading clinical trials to improve imaging and detection of ILC, helping patients get earlier and more accurate diagnoses and better treatment pathways. Breast cancer is not one disease. Understanding its different types and advancing research ensures every patient receives the care they need when it matters most. 💗 #LobularBreastCancerAwarenessDay

We're #hiring a new Patient Transport : Support Services (SCT) - Part Time - 08HR - Hoag Newport Beach in Newport Beach, California. Apply today or share this post with your network.

Can AI help people with IBD get better care, faster? That’s the question explored in TIME Health's latest issue, and Dr. Caroline Hwang, Director of the Margolis Family Inflammatory Bowel Disease Program at the Hoag Digestive Health Institute, shared how her team is already exploring the possibilities. Dr. Hwang discussed how AI tools are beginning to assist in real-time documentation, helping physicians focus more on patients, and how advanced technologies — like Medtronic’s GI Genius — could one day help detect precancerous changes earlier, prevent colon cancer, and reduce unnecessary surgeries. She also shared her vision for how AI could support clinicians in choosing the right biologic treatments, ease administrative burdens such as insurance approvals, and help reduce “cognitive overload” in reviewing complex imaging and test data. At Hoag, Dr. Hwang and her colleagues are leading the way in pairing compassionate, expert-driven care with innovation that could redefine the future of IBD treatment. 👇 Read the full TIME Health article: “Can AI help people with IBD get better care, faster? The emerging tech could be a game-changer.”

We're #hiring a new Nurse Practitioner : Cardiac Administration in Newport Beach, California. Apply today or share this post with your network.